Deoxyuridine powder injection and its preparing method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU SHENLONG PHARMA
- Publication Date
- 2007-04-11
Abstract
Description
technical field
[0001] The invention relates to doxifluridine powder injection and a preparation method thereof, in particular to doxifluridine freeze-dried powder injection suitable for infusion and a preparation method thereof. technical background
[0002] Doxifluridine (5'-DFUR) is a nontoxic prodrug of 5-fluorouracil (5-FU). It is an anti-tumor drug developed by the American branch of Roche in the 1970s, and its trade name is Furtulon. It was first put into the market in Japan in the 1990s. In the past, the fluorinated pyrimidine series drugs were mainly enzymatically or naturally hydrolyzed into 5-FU by liver drug enzymes after oral administration. In contrast, Fluferolone can be converted into 5-FU by pyrimidine nucleoside phosphorylase (PyNPase), which shows high activity in tumor tissue. Because the enzyme is high in breast cancer, gastric cancer, colon cancer and other solid tumors, 5'-DFUR is preferentially activated in the tumor site, and the drug concentratio...